Cargando…
G6PC mRNA Therapy Positively Regulates Fasting Blood Glucose and Decreases Liver Abnormalities in a Mouse Model of Glycogen Storage Disease 1a
Glycogen storage disease type Ia (GSD1a) is an inherited metabolic disorder caused by the deficiency of glucose-6-phosphatase (G6Pase). GSD1a is associated with life-threatening hypoglycemia and long-term liver and renal complications. We examined the efficacy of mRNA-encoding human G6Pase in a live...
Autores principales: | Roseman, Daniel S., Khan, Tayeba, Rajas, Fabienne, Jun, Lucy S., Asrani, Kirtika H., Isaacs, Cleo, Farelli, Jeremiah D., Subramanian, Romesh R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5910675/ https://www.ncbi.nlm.nih.gov/pubmed/29428299 http://dx.doi.org/10.1016/j.ymthe.2018.01.006 |
Ejemplares similares
-
SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency
por: Connolly, Brendan, et al.
Publicado: (2018) -
Optimization of mRNA untranslated regions for improved expression of therapeutic mRNA
por: Asrani, Kirtika H., et al.
Publicado: (2018) -
Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases
por: Pursell, Natalie, et al.
Publicado: (2018) -
mRNA therapy restores euglycemia and prevents liver tumors in murine model of glycogen storage disease
por: Cao, Jingsong, et al.
Publicado: (2021) -
Cellular and metabolic effects of renin-angiotensin system blockade on glycogen storage disease type I nephropathy
por: Monteillet, Laure, et al.
Publicado: (2021)